RESILIENT : a Self-Managed Online Platform for Victims of Sexual Assault
Launched by LAVAL UNIVERSITY · Mar 31, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
The RESILIENT trial is studying a new online platform designed to help individuals who have experienced sexual assault manage their mental health. It focuses on treating issues like post-traumatic stress disorder (PTSD), insomnia, and depression through a self-managed online approach. This trial aims to understand if this type of treatment, which may be done without a therapist's help, is effective and acceptable for those affected. Researchers will recruit 204 participants who identify as women, are at least 18 years old, and have experienced sexual assault after age 12. Participants must also have access to the internet and show some signs of PTSD and depression.
If you join the study, you will be randomly assigned to either a self-managed online treatment group or a group that receives help from a therapist. Throughout the trial, you will fill out questionnaires to track your mental health symptoms before, during, after, and three months after the treatment. This study could provide important insights into how self-help online programs can support recovery for those dealing with the aftermath of sexual assault, filling a crucial gap in mental health services for this population.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Identify at least in part as a woman;
- • 2. Be at least 18 years old;
- • 3. Have experienced SA after the age of 12;
- • 4. Read and speak French;
- • 5. Have adequate Internet access; and f) Present with some post-traumatic stress symptoms (PCL-5 ≥ 10) AND at least mild depressive symptoms (PHQ-9 ≥ 5) AND/OR subclinical insomnia symptoms (ISI ≥ 8).
- Exclusion Criteria :
- • 1. Bipolar or psychotic disorder;
- • 2. High suicidal risk, or any other condition requiring immediate intervention;
- • 3. Already benefiting from a psychological intervention.
About Laval University
Laval University is a prestigious research institution located in Quebec, Canada, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. The university actively engages in clinical trials aimed at exploring new therapeutic interventions and improving patient outcomes. With a strong emphasis on ethical standards and rigorous scientific methodologies, Laval University collaborates with multidisciplinary teams of researchers, healthcare professionals, and industry partners to conduct high-quality clinical research. Its state-of-the-art facilities and dedication to fostering a culture of inquiry position Laval University as a leader in clinical research, contributing significantly to the understanding and treatment of diverse medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Québec, Quebec, Canada
Québec, , Canada
Patients applied
Trial Officials
Genevieve Belleville, Ph.D.
Principal Investigator
Laval University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials